Sorafenib for the treatment of advanced hepatocellular carcinoma

• M Connock,
• J Round,
• S Bayliss,
• S Tubeuf,
• W Greenheld,
• D Moore

Affiliations

M Connock

Unit of Public Health, Epidemiology and Biostatistics, University of Birmingham, Edgbaston, Birmingham, UK

J Round

Institute of Health Sciences, University of Leeds, Leeds, UK

S Bayliss

Unit of Public Health, Epidemiology and Biostatistics, University of Birmingham, Edgbaston, Birmingham, UK

S Tubeuf

Institute of Health Sciences, University of Leeds, Leeds, UK

W Greenheld

Unit of Public Health, Epidemiology and Biostatistics, University of Birmingham, Edgbaston, Birmingham, UK

D Moore

Unit of Public Health, Epidemiology and Biostatistics, University of Birmingham, Edgbaston, Birmingham, UK